With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

In this week’s edition of InnovationRx, we look at the FDA's new rules on Covid-19 vaccines, Novartis’s acquisition strategy, ...

Amgen’s AMGN stock has declined 10.4% in the past three months. A lot of this price decline is related to the broader ...

Eli Lilly's gene-silencing drug lepodisiran has been shown to reduce ... However, unlike LDL-cholesterol, there are currently no drugs approved that can reduce levels of the lipoprotein in the ...